Guardian corrects A&E deaths and climate aid articles
The Guardian has issued clarifications regarding a report on A&E waiting times and a story on international climate aid. Read the full details of the corrections here.
The Guardian has issued clarifications regarding a report on A&E waiting times and a story on international climate aid. Read the full details of the corrections here.
A Guardian investigation reveals a company linked to a major MHRA raid continues to sell unlicensed weight-loss drugs on Telegram, posing serious health risks. Learn the dangers of counterfeit retatrutide.
Hyperbaric oxygen therapy is FDA-approved for only 13 conditions, yet some clinics market it for over 100. Experts warn of deadly risks and call for urgent regulation.
A UK company director has pleaded guilty to a global fraud involving counterfeit aircraft engine parts, leading to hundreds of grounded flights. Full story on the aviation safety scandal.
Europol confiscates over 8 million dangerous counterfeit toys worth £8m in pre-Christmas crackdown. Protect your children from unsafe products this festive season.
Discover how ancient Indigenous food wisdom offers solutions to modern health and environmental crises. Learn why food sovereignty is key to our collective future.
Wellness influencers are drinking methylene blue dye despite serious health risks. Learn why this textile dye is causing concern among medical experts and poison centres.
Over 100 counterfeit Labubu toys posing a choking hazard have been seized in Reading. Discover how to spot dangerous fakes and protect your children this Christmas.
Three-year-old Oliver Chu shows dramatic improvement after groundbreaking gene therapy for Hunter syndrome at Manchester hospital. A potential alternative to lifelong treatment.
Dr Stephen Dawson, who witnessed London's Aids crisis in the 1980s, transformed sexual healthcare in Slough. Read his remarkable story from urology to film-making.
The UK government accelerates its plan to replace animal testing with advanced alternatives like 'organs-on-chips' and 3D bioprinting. Discover the timeline and the science behind this ethical shift.
Explore the science behind PEMF therapy mats. Experts weigh in on their potential for pain relief versus evidence-based treatments for chronic conditions in the UK.
The Metropolitan Police has seized £240k in counterfeit goods and £22k cash in a major operation targeting money laundering and organised crime across 30 London venues. Read the full story.
UK authorities warn of sophisticated fake weight-loss drugs manufactured by organised crime. Learn how to spot counterfeit products and protect your health.
Met Police crackdown uncovers dangerous counterfeit electronics and illegal vapes sold to children in south London. Discover how Operation Machinize 2 is tackling organised crime.
The CEO of pharmaceutical giant AstraZeneca warns that UK patients may be limited to generic medicines unless the NHS increases what it pays for innovative new treatments, raising concerns about healthcare quality and medical research funding.
Australian authorities sound alarm over counterfeit Labubu dolls containing hazardous materials. Discover how to spot fakes and protect your family from serious safety risks.
Health authorities issue critical safety alert about prescription medication storage as temperatures rise across the UK
Groundbreaking research reveals how museums, galleries and cultural experiences are being prescribed by doctors to treat everything from chronic pain to mental health conditions, transforming healthcare in Britain.
Exclusive investigation reveals how British consumers are being targeted by sophisticated fraudsters selling counterfeit weight loss injections online, with experts warning of serious health risks.
A leading sports injury expert breaks down Alexander Isak's latest fitness concern and what it means for Liverpool's Premier League campaign.
A critical pricing dispute between the UK government and pharmaceutical companies threatens patient access to vital medicines, with industry leaders warning of treatment delays and reduced NHS access to new drugs.